STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)		1 Months Ended		3 Months Ended		5 Months Ended	12 Months Ended
	Oct. 05, 2017	Dec. 20, 2018	Dec. 18, 2018	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Reverse stock split							one (1) for ten (10) basis
Conversion of common stock	13,732,400
Common stock converted into convertible Preferred Stock	137,324
Conversion basis	Each share of Series A Preferred into 100 shares of common stock of the Company
Common Stock, Shares Issued				20,850,848	20,765,592	20,765,592	20,850,848	20,765,592
Common Stock, Shares Outstanding				20,850,848	20,765,592	20,765,592	20,850,848	20,765,592
Sale of remaining common stock				19,392,401			19,392,401
Proceeds from warrants							$ 63,811
Proceeds from sale of common stock and warrants							$ 0
Warrants exercised							6,136
Warrants outstanding				185,570			185,570
Distribution Agreement
Number of common stock sold						23,500	14,338
Proceeds from common stock sold						$ 455,105	$ 152,492
Related cost						$ 161,102	$ 40,365
Placement agency agreement
Number of common stock sold		194,206	240,000
Public offering price			$ 10.4
Sale of warrants		194,206
Proceeds from warrants		$ 2,019,743
Proceeds from sale of common stock and warrants		1,691,541
Placement agent commissions		$ 328,302
Warrants exercisable			$ 13.0
Warrants term			3 years
Share capital
Anti-dilutive common stock				1,000,000	1,000,000		1,000,000	1,000,000
Warrants [Member]
Anti-dilutive common stock							185,570	188,070
Warrants One [Member]
Anti-dilutive common stock							9,710	9,710
Warrants One [Member] | Placement agency agreement
Anti-dilutive common stock			9,710
Option [Member]
Anti-dilutive common stock							9,710	9,710
Option [Member] | Placement agency agreement
Anti-dilutive common stock			9,710